Williams Jones Wealth Management, Llc. Spero Therapeutics, Inc. Transaction History

Williams Jones Wealth Management, Llc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.74 - $7.44 $5,180 - $52,080	-7,000 Reduced 26.92%	19,000 $14,000
Q1 2022 May 16, 2022	SELL	$7.87 - $15.15 $385,630 - $742,350	-49,000 Reduced 65.33%	26,000 $226,000
Q4 2021 Feb 14, 2022	SELL	$13.09 - $18.77 $399,245 - $572,485	-30,500 Reduced 28.91%	75,000 $1.2 Million
Q3 2021 Nov 15, 2021	BUY	$13.03 - $19.51 $1.37 Million - $2.06 Million	105,500 New	105,500 $1.94 Million

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $40.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Williams Jones Wealth Management, Llc., based on Form 13F filings with the SEC.

Stay updated on Williams Jones Wealth Management, Llc. with notifications on news.